Enifer XT (150 ml) is a Fixed-Dose Combination (FDC) Drug Brand being manufactured and marketed by Enivid Life Sciences. This medicine is combination of more than one active ingredient or substance within a single pharmaceutical form type. The main active ingredients or salts in this drug are Folic Acid (Vit B9), Ferrous Ascorbate,Zinc Sulphate. This drug comes in the form of Syrup. The general packing available for this medicine consists of 150 ml and is priced at Rs 100 (arround $1.4 US Dollar)
The main active ingredients or salts in Enifer XT (150 ml) are :
Ferrous Ascorbate-100 mg
Folic Acid (Vit B9)-1.5 mg
Zinc Sulphate-22.5 mg
Folic Acid (Vit B9) Indication (Prescribed for or used as): Folate-deficient. Megaloblastic anaemia. Prophylaxis of megaloblastic anemia in pregnancy. Prophylaxis of neural tube defect in pregnancy. Malabsorption syndromes. Antiepileptic therapy.
For more details on Folic Acid (Vit B9), its Indication, Prescription, Usage, Dosage, Precaution, Side Effects etc, please check : Folic Acid (Vit B9)..
Ferrous Ascorbate Indication (Prescribed for or used as):
For more details on Ferrous Ascorbate, its Indication, Prescription, Usage, Dosage, Precaution, Side Effects etc, please check : Ferrous Ascorbate..
Zinc Sulphate Indication (Prescribed for or used as): For eye and ear wash. Acne and impetigo.
For more details on Zinc Sulphate, its Indication, Prescription, Usage, Dosage, Precaution, Side Effects etc, please check : Zinc Sulphate..
Enifer XT (150 ml) Drug Brands Substitutes with similar Fixed-Dose Combination (FDC) :
There are 3 Fixed-Dose Combination (FDC) Drug Brands listed here as Substitutes for Enifer XT (150 ml), which have same Fixed-Dose Combination of active substances or ingredients (i.e. Ferrous Ascorbate-100 mg Folic Acid (Vit B9)-1.5 mg Zinc Sulphate-22.5 mg). Please note that one can request a doctor or pharmacist to substitute a FDC Brand Version of the prescribed FDC drug brand, if any. Fixed-Dose Combination Drugs are being increasingly used due to the benefit of the combined effects of active ingredients given together. However, it is necessary to investigate the possible benefits in the clinical situation against possible disadvantages for each fixed combination drug and for each dose of the fixed combination drug. Potential advantages of fixed combination drugs may also include the counteracting by one ingredient of an adverse reaction produced by another one, and simplification of therapy, leading to improved compliance.